Expandable ECMO extension cannula system
By using a self-expanding catheter and a direct connector in the VA-ECMO system, blood can be delivered directly to the thoracic aorta, reducing the risk of kidney injury and stroke, simplifying the delivery of interventional devices, and reducing vascular trauma and complications.
Patent Information
- Application Number
- CN202180033148.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-04-03
- Filing Date
- 2021-04-01
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2041-04-01
AI Technical Summary
Existing venous-arterial extracorporeal membrane oxygenation (VA-ECMO) systems have problems such as kidney damage, increased risk of stroke, vascular damage and high incidence of complications during use, especially organ damage and increased pressure caused by high flow rate and non-pulsatile blood flow.
Employing an extension cannula and a direct-insertion connector, the extension cannula delivers oxygenated blood directly to the thoracic aorta via a self-expanding catheter, improving blood flow to the brain and descending aorta and reducing the risk of kidney damage; the direct-insertion connector provides a simple and effective access method, allowing for the delivery of additional interventional devices.
It increases blood flow to the brain and aortic arch, reduces the risk of renal reperfusion injury and stroke, minimizes vascular trauma, simplifies the delivery of interventional devices, and reduces the incidence of complications.
Smart Images

Figure CN115515661B_ABST
Abstract
Description
Technical Field
[0001] This application generally relates to systems and methods for improving systemic perfusion and reducing complications during venous-arterial extracorporeal membrane oxygenation (VA-ECMO), and more specifically, to improving perfusion using in-line connectors and self-expanding extension cannulas to deliver oxygenated blood directly to the thoracic aorta. Background Technology
[0002] Arterial perfusion in each major organ system (including the heart, kidneys, and brain) is determined by arterial pressure, blood flow, vascular tone, and intra-organ vascular resistance. When patients experience low arterial perfusion due to heart failure, cardiopulmonary failure, or cardiogenic or septic shock, venous-arterial extracorporeal membrane oxygenation (VA-ECMO) systems can be used to provide circulatory and gas exchange support by increasing the flow of oxygenated blood. See, for example, Pavlushkov E, Berman M, Valchanov K. Cannulation techniques for extracorporeal life support. Ann Transl Med 2017;5(4):70. doi:10.21037 / atm.2016.11.47. Specifically, VA-ECMO drains blood from the venous system, oxygenates the blood outside the patient's body, and then returns the oxygenated blood to the arterial system via, for example, the femoral artery. VA-ECMO is typically performed via a large-bore cannula (called peripheral VA-ECMO) placed in the femoral vein and femoral artery. VA-ECMO is an established cardiopulmonary support strategy. The diameter of large-bore ECMO cannulas for adults is typically in the range of 15 Fr (5.0 mm) to 25 Fr (8.3 mm), and the blood flow rate used to deliver life-sustaining blood is between 3 and 8 liters per minute.
[0003] Despite the increasing use of VA-ECMO, with nearly 5,000 extracorporeal membrane oxygenation (ECMO) devices in use annually in the US alone, the in-hospital mortality rate remains around 60%. One explanation for these adverse outcomes is that peripherally cannulated VA-ECMO may lead to kidney injury, increase the risk of stroke, and promote cerebral ischemia, hemorrhage, and vascular injury. Furthermore, more than one large-diameter cannula may be required to achieve the high flow rates needed for systemic perfusion with VA-ECMO. The number and size of the cannulas are directly associated with an increased risk of hemorrhage, vascular trauma, and acute limb ischemia. Finally, peripherally cannulated VA-ECMO may compress the entire aorta and increase intracardiac pressure, which increases fluid in the lungs, potentially leading to acute lung injury. To mitigate lung injury, methods such as intra-aortic balloon pumps and... Companion devices such as pumps (manufactured by AbioMed, Danvers, and Massachusetts) can be used concurrently with VA-ECMO, but require additional vascular access. All of these complications are associated with increased mortality, long-term morbidity, length of hospital stay, and medical costs. New methods are needed to limit VA-ECMO-related complications.
[0004] Studies have shown that VA-ECMO support may reduce kidney function and even lead to acute kidney injury due to increased arterial pressure and loss of pulsatile blood flow to the kidney, caused by high blood flow velocities in the outlet region of the arterial outlet return cannula in conventional VA-ECMO. This damage may, in turn, activate the kidney's autoregulatory mechanisms. For example, high-velocity nonpulsatile blood flow encountered with conventional VA-ECMO cannulas has been observed to increase vascular resistance, which in turn increases the workload of the kidney and exacerbates oxygen consumption. Up to 70% of patients receiving VA-ECMO experience acute kidney injury, which is directly associated with mortality. Further studies have shown that VA Emay leads to a significant increase in arterial flow and promotes increased intra-organ pressure, thereby reducing flow in the renal vein. Therefore, the net effect of VA-ECMO with conventional return cannulas is increased intra-organ pressure, resulting in reduced flow through the kidney. These physiological findings are associated with increased biomarkers of kidney injury, suggesting that one mechanism leading to kidney injury may be related to the buildup of intra-renal pressure and a net reduction in blood flow through the kidney.
[0005] Previous efforts to reduce perfusion injury are known in the art. For example, U.S. Patent No. 6,083,198 to Afzal describes a perfusion catheter with segmented flow regions, wherein the arterial return catheter includes a series of orifices along its length to distribute blood more evenly within the aorta (including the aortic arch). However, a drawback of the system described in this patent is that the diameter of the inner catheter is smaller than that of the outer catheter, thereby reducing the flow velocity at the distal portion of the catheter.
[0006] Recent studies have also shown that VA-ECMO increases the risk of stroke, such as acute ischemic stroke and hemorrhagic stroke. Because VA-ECMO induces retrograde blood flow in the femoral artery to the aorta, the brain is the last major organ to receive oxygenated blood delivered via a conventional femoral cannula. Furthermore, in patients presenting with North-South syndrome, for example when impaired lung function causes deoxygenated blood to be ejected from the left ventricle into the ascending aorta, differential hypoxia may occur because VA-ECMO patients rely on retrograde blood flow to deliver oxygenated blood to the upper body. To mitigate this effect, doctors currently make additional vascular punctures in the artery or vein to place additional large-bore cannulas, which increases the risk of complications.
[0007] Central VA-ECMO, in which oxygenated blood is delivered directly to a central location, for example via surgical cutting of the aortic arch, has been presumed to provide more oxygenated blood to the brain, thereby reducing the risk of stroke. However, such cannulation, as described, for example, in Afzal's U.S. Patent No. 6,210,365, requires invasive surgery and involves additional potential complications. A theoretically alternative solution is to deliver oxygenated blood directly to the patient's venous side via the ECMO cannula; however, this would require creating additional large-bore punctures in the patient's vascular system and could further complicate matters due to the cannula already present in the venous circulation in the original VA-ECMO configuration. Furthermore, placing a rigid cannula in the central location of the thoracic aorta from a peripheral artery may be limited because it is impossible to pass through the iliofemoral bifurcation, tortuous aorta, or calcified aorta (containing atherosclerotic material) using a large-bore cannula.
[0008] In view of the above, it is desirable to provide a system and method for delivering oxygenated blood from the femoral artery inlet point via VA-ECMO to a more central location in the patient (e.g., the thoracic aorta) to supply oxygenated blood to the brain and induce antegrade blood flow to the lower part of the descending aorta. Such a system and method could thereby improve blood flow to the brain, protect brain function, reduce the risk of ischemic stroke, and reduce blood flow velocity and pressure that could lead to kidney damage.
[0009] Anderson's U.S. Patent No. 8,996,095 describes a coronary artery guiding extension catheter with a push member and a distal tubular member configured to be positioned in the coronary artery for use during percutaneous transluminal coronary angioplasty. The guiding extension catheter described in this patent is designed to stabilize the distal end of the coronary artery guiding catheter to prevent it from moving away from the patient's ostium due to cardiac activity during the interventional procedure. Similarly, O'Donovan's U.S. Patent No. 10,485,956 describes a guiding extension catheter with a groove in the push member and a distal shaft for guiding an interventional coronary artery device through which it passes. Due to the small lumen diameter, resulting in low achievable blood flow, this coronary artery guiding extension catheter is unsuitable for use as an infusion cannula in VA-ECMO. The fixed diameter of guiding extension catheters is typically between 6Fr (2 mm) and 8Fr (2.7 mm). These coronary artery guiding extension catheters are not designed to change the direction of blood flow, but rather to facilitate the delivery of coronary devices to the distal portion of the coronary vascular system.
[0010] Hogendijk's U.S. Patent No. 6,632,236 describes a self-expanding catheter for stent delivery, wherein the catheter is inserted through the lumen in a contracted delivery state and self-expands to an expanded state upon removal of the delivery sheath. This patent describes a self-expanding anchor formed from a self-expanding filament fabric with an elastic polymer coating, configured to prevent embolism during vascular intervention. The concept described in Hogendijk is not intended to alter blood flow direction, but rather to filter out elements in the blood flow. Similarly, Kratoska's U.S. Patent No. 6,183,443 describes an expandable catheter sheath for percutaneous insertion of an intravascular angioplasty catheter. This self-expanding catheter has not yet been considered for use with VA-ECMO systems to perfuse oxygenated blood.
[0011] Given the known drawbacks of ECMO perfusion catheters, it is desirable to provide a device for use with ECMO systems that can enhance blood flow to the thoracic aorta and aortic arch, improve cerebral oxygenation, maintain systemic arterial pulsatility, and reduce the likelihood of renal perfusion injury using a single access port, thereby avoiding the bleeding and vascular damage associated with contemporary VA-ECMO.
[0012] It is further desirable to provide a device for ECMO systems that avoids the low-flow lumen size of previously known reperfusion catheters, thereby allowing increased blood flow velocity in the ascending aorta and aortic arch, while maintaining or reducing the diameter of the femoral artery vascular opening required for the introduction of the reflux cannula.
[0013] In contemporary practice, VA-ECMO is also used to support common life-saving procedures such as coronary angioplasty, aortic valve repair, or aortic valve replacement. However, a major limitation of these methods is that, in addition to the existing VA-ECMO circuit, an additional vascular access is required to place the vascular sheath and / or catheter for the necessary interventional device. This may be contraindicated in patients with peripheral vascular disease, concomitant vascular injury, or whose vessels are occupied by other life-saving devices. Furthermore, establishing additional vascular access in emergency situations can be challenging and increase the risk of injury.
[0014] U.S. Patent Nos. 5,125,903, 5,195,980, 5,269,764, and 7,938,809 describe percutaneous catheter inserters / connectors with hemostatic valves to allow slender interventional devices into a patient's vascular system, and side ports for connection to, for example, external perfusion sources, aspiration sources, contrast agents, drugs, etc. These systems are not designed for use with VA-ECMO. Furthermore, existing methods do not allow for easy and efficient access to the VA-ECMO circuit to deliver additional interventional devices. Current Y-connectors for accessing ECMO circuits have several drawbacks, including a reduced effective lumen of the ECMO return cannula, the creation of undesirable pressure gradients, and difficult angle requirements—preventing the introduction of additional catheters without the risk of kinking or catheter rupture. Due to the insertion of the connecting cannula, these previously known connectors require inserting the inserter sheath 25 to 30 cm further than usual, thus limiting access to the thoracic aorta, aortic root, aortic valve, or coronary vascular system. During ECMO disconnection and reconnection, this connector also carries a risk of bleeding, and the risk of air embolism and contamination increases due to disconnection from the ECMO circuit. See, for example, Dmitriy S. Sulimov, MD et al., “Rescue Peripheral Intervention Using a Peripheral ECMO-Cannula as Vascular Access,” J Am Coll Cardiol Intv. 2020 Jan 29. Epublished DOI:10.1016 / j.jcin.2019.11.038.
[0015] Therefore, it is desirable to provide a connector that allows for simple and efficient access to the ECMO circuit for the delivery of interventional devices. Summary of the Invention
[0016] According to the principles of the present invention, devices and methods for use with ECMO systems are provided that overcome the drawbacks of previously known ECMO reperfusion catheters. Specifically, the devices constructed according to the present invention can enhance blood flow to the thoracic aorta, improve cerebral oxygenation, maintain systemic arterial pulsatility, reduce the likelihood of distal organ injury, and allow delivery of additional interventional or vascular equipment using a single access port, thereby avoiding the bleeding and vascular injury associated with contemporary VA-ECMO.
[0017] According to one aspect of the invention, an extension cannula is provided for use with a conventional ECMO return cannula. The extension cannula includes an elongated shaft having proximal and distal regions, and a catheter coupled to the distal region of the elongated shaft. The elongated shaft can be used to position a proximal end in fluid communication with the lumen of a conventional ECMO return cannula, such that the distal end of the catheter extends beyond a renal artery, for example, within the thoracic or abdominal aorta. The shaft may include a proximal end extending through a port near the proximal end of the ECMO return cannula, where a clinician can manipulate it. The catheter has an inlet, an outlet, an internal lumen extending therebetween, and a diameter configured to transition between a contracted insertion state and an expanded deployment state. The catheter inner diameter can be custom-sized and shaped to receive catheters for coronary, peripheral vascular, cerebral, or valvular interventions, catheters for antegrade limb perfusion, or catheters for delivery via an intra-aortic pump, a transvalvular pneumatic pump, or a cyclone pump.
[0018] In a preferred embodiment, the catheter has a selected length such that when the extension cannula is inserted through the lumen of a conventional ECMO return cannula, the inlet of the catheter is in fluid communication with the outlet of the conventional ECMO return cannula, and the outlet of the catheter extends beyond the renal artery and may be located in the patient's thoracic aorta, for example, the descending aorta, aortic arch, or ascending aorta. According to the principles of the invention, as used herein, the patient's thoracic aorta may include a portion of the descending aorta above the diaphragm level, such that the outlet of the catheter may be located in the descending aorta, from below the patient's thoracic cavity near the diaphragm level. The catheter may include a support structure, such as a self-expanding mesh, fabric, or braid encapsulated with a tough biocompatible coating (ePTFE). Optionally, the support structure may include shape memory alloys, plastic, or stainless steel spines or skeletons. As a further alternative, the catheter may take the form of a hollow sock structure having one or more holes connected to the tough spines. For example, multiple holes may be provided in the side surface of the catheter. In this latter embodiment, the sock structure expands when filled with blood ejected from the ECMO circuit. For example, the catheter can be made of a soft, flexible material that allows it to unfold as blood is pumped through the internal lumen by the ECMO system. Multiple pores in the soft, flexible material allow blood to exit the lumen without ejection.
[0019] The extended cannula of the present invention is intended to provide improved oxygenated blood delivery from an ECMO machine. For example, the catheter may have a selected length such that when the extended cannula is inserted through the lumen of the ECMO return cannula and transitions to an expanded state, for example, when there is blood flow from the ECMO machine, the inlet of the catheter can be in fluid communication with the outlet of the ECMO return cannula, the outlet of the catheter can extend beyond the patient's renal vessels, for example, into the aortic arch, and the internal lumen can form a continuous blood flow path through the internal lumen to deliver blood flow from the ECMO machine beyond the patient's renal vessels, for example, to the patient's aortic arch, thereby reducing cardiac load on the patient's left and right ventricles. Furthermore, the reduction in cardiac load can reduce left ventricular injury and the long-term effects of myocardial infarction.
[0020] The extension cannula may further include a sheath sized and shaped to be removably disposed on the catheter to hold the catheter in a retracted insertion state. Additionally, a support structure near the catheter inlet may include a feature that facilitates the catheter's transition to a retracted insertion state as the sheath is advanced on the catheter. For example, the feature may include a tapered geometry at the proximal end of the support structure. Optionally, the feature may include multiple support legs connecting the proximal end of the support structure to an elongated shaft.
[0021] According to another aspect of the invention, the extension cannula of the invention may include a through-hole connector having a first branch configured to connect to an outlet of an ECMO circuit, a second branch configured to allow insertion of the extension cannula, and an outlet configured to connect to a conventional ECMO return cannula. The first and second branches are in fluid communication with the outlet of the through-hole connector, and the second branch is preferably collinear with the outlet of the through-hole connector. The through-hole connector may be removably connected to a conventional ECMO return cannula, or it may be incorporated as a single unit into a conventional ECMO return cannula.
[0022] The size and shape of the lumen extending from the second branch to the outlet of the direct-access connector can preferably be configured to receive an extension cannula, a catheter for coronary, peripheral vascular, cerebral, or valvular intervention, a catheter for antegrade limb perfusion, or a catheter for delivering at least one of an aortic pneumatic pump, a transvalvular axial flow pump, or a cyclone pump. The direct-access connector can also be used to provide wire re-access to natural femoral vessels, allowing removal of the ECMO cannula and delivery of a vascular closure device during ECMO extubation, thereby avoiding the need for surgical vascular repair. The direct-access connector of the present invention may also include a side arm for flushing the direct-access connector, which can be connected to an antegrade perfusion sheath to deliver oxygenated blood to prevent limb ischemia.
[0023] The second branch of the through-hole connector may include a specially designed hemostatic valve, which can be directly integrated into the through-hole connector or designed to connect to a standard ECMO cannula or fitting to facilitate cannula insertion, replacement, or removal. Preferably, the specially designed hemostatic valve can be a stand-alone component that can be integrated into an existing ECMO circuit.
[0024] Furthermore, the plug-in connector may include an end cap configured to engage with the inlet of a second branch of the plug-in connector. The end cap may also include dual hemostatic valves. Optionally, the end cap may include a plug sized and shaped to be received within the lumen of the second branch of the plug-in connector, thereby preventing blood pooling as oxygenated blood flows from the first branch to the outlet of the plug-in connector. Additionally, the end cap may include a lumen sized and shaped to receive at least one of a drug infusion catheter or a pressure or flow sensor.
[0025] According to another aspect of the invention, the ECMO cannula can be configured to be positioned via the femoral vein, wherein the inlet of the extended cannula is located within the patient's pulmonary artery, thereby serving as a cannula capable of selectively drawing blood from the pulmonary artery into the ECMO circuit. In this way, the flow through the lungs is reduced by decreasing the preload of the left ventricle, thereby reducing stress and dilation of the left ventricular wall.
[0026] As a further alternative, the outlet of the extended cannula can be positioned at the root of the aorta or in the left ventricle of the patient, and can be sized to receive catheters for coronary, peripheral, cerebrovascular, or valvular interventions, or for placement of additional pumping techniques in the left ventricle (such as an intra-aortic pneumatic pump or cyclone pump, e.g., an intra-aortic balloon pump (IABP), or a transvascular cyclone pump (e.g., At least one of the catheters of a pump (available from AbioMed, Danvers, Massachusetts).
[0027] According to another aspect of the invention, an extension cannula having an inlet and an outlet is provided for use with an ECMO inlet cannula. The extension cannula includes an elongated shaft having proximal and distal regions, and an expandable catheter coupled to the distal region of the elongated shaft. The catheter has an inlet, an outlet, and an internal lumen, and has a diameter that transitions between a contracted insertion state and an expanded deployment state. The catheter has a selected length such that when the extension cannula is inserted through the lumen of the ECMO inlet cannula, the outlet of the catheter is in fluid communication with the outlet of the ECMO inlet cannula, and the inlet of the catheter is located within the patient's right ventricle.
[0028] Methods of using the extended cannula of the present invention are also provided. For example, the extended cannula of the present invention can be used to reduce or prevent myocardial injury in subjects caused by acute myocardial infarction, heart failure, cardiac arrest, pulmonary embolism, myocarditis, or lung injury. Furthermore, the extended cannula of the present invention can be used to reduce the area of myocardial infarction due to obstruction of coronary blood flow and limit the development of post-infarction heart failure. In addition, the extended cannula of the present invention can be used to increase cardioprotective signal transduction pathways in the heart during acute myocardial infarction or heart failure to reduce myocardial injury and improve myocardial recovery.
[0029] According to another aspect of the invention, a valve is provided for use with an ECMO return cannula. The valve may include an end cap that is fluidly coupled to an ECMO circuit. The end cap has a proximal end, a distal end that is coupled to the ECMO return cannula, and a lumen extending therebetween. The size and shape of the lumen may be configured to receive at least one of the following: an extension cannula, a catheter for coronary, peripheral vascular, cerebral, or valvular intervention, a catheter for antegrade limb perfusion, or a catheter for intra-aortic, valve-pneumatic, or cyclone pump delivery, a drug infusion catheter, a pressure or flow sensor, or a replacement ECMO return cannula. Preferably, the specially designed end cap may be a separate component that can be incorporated into an existing ECMO circuit. In a preferred embodiment, the valve includes a hemostatic valve disposed within the lumen of the end cap, such that the hemostatic valve allows unidirectional blood flow from the ECMO circuit to the ECMO return cannula. The proximal end of the end cap may be configured for fluid coupling to the ECMO circuit, while the distal end of the end cap may be coupled to the ECMO return cannula via a through-hole connector as described above. The size and shape of the end cap lumen are preferably configured to allow removal of the ECMO reflux cannula and delivery of a second ECMO reflux cannula that is larger than the original ECMO reflux cannula. Attached Figure Description
[0030] Figure 1A This is a side view of an extension catheter constructed according to the principles of the present invention for improving reperfusion during ECMO, wherein the extension catheter is in an expanded state and wherein the delivery sheath is removed.
[0031] Figure 1B yes Figure 1A A side view of the extension sleeve, wherein the extension sleeve is in a retracted state within the delivery sheath.
[0032] Figure 2 yes Figure 1A A side view of an alternative embodiment of the extension cannula, wherein the extension cannula is in an expanded state and the delivery sheath has been removed.
[0033] Figure 3A This is a schematic diagram of an exemplary through-hole connector configured for use with the extension sleeve of the present invention.
[0034] Figure 3B It shows the relationship with Figure 3A End caps used in conjunction with through-hole connectors.
[0035] Figures 4A-4C This is a schematic diagram illustrating the use of an exemplary through-hole connector with an exemplary extension sleeve in an ECMO system.
[0036] Figure 4D This is a schematic diagram illustrating the use of an exemplary through-hole connector with an optional exemplary extension sleeve in an ECMO system.
[0037] Figure 5 This is a flowchart illustrating exemplary steps for improving perfusion during ECMO according to the principles of the present invention.
[0038] Figures 6A-6E Exemplary steps for improving perfusion during ECMO using the extended cannula of the present invention are shown.
[0039] Figure 7 This is a graph illustrating the stroke risk associated with VA-ECMO.
[0040] Figure 8 The North-South syndrome in patients on ECMO was described.
[0041] Figure 9 This is a series of figures showing various parameters of standard conventional ECMO cannulation compared to those achieved using alternative cannulation techniques (delivering blood to the thoracic aorta) based on the principles of the present invention.
[0042] Figure 10 This is a series of figures illustrating various parameters generated using standard conventional ECMO cannula insertion, an Impella pump, and the exemplary system of the present invention.
[0043] Figure 11 These are a series of graphs representing renal artery blood flow velocities obtained by standard conventional ECMO cannula insertion and the exemplary alternative (irrigation) cannula insertion system of the present invention.
[0044] Figure 12 This is a graph illustrating renal artery pulsatility and renal artery microvascular resistance in a standard conventional ECMO cannula insertion procedure and an exemplary alternative cannula insertion system of the present invention.
[0045] Figure 13 This is a graph showing the urinary levels of kidney injury molecules associated with standard conventional ECMO cannulation and the exemplary alternative cannulation system of the present invention.
[0046] Figure 14A The left and right ventricular responses are shown during a routine ECMO cannula insertion procedure.
[0047] Figure 14B The left and right ventricular responses during ECMO using the extended cannula of the present invention are shown. Detailed Implementation
[0048] Systems and methods for use with ECMO systems are provided to enhance blood flow to the thoracic aorta, ascending aorta, and aortic arch, thereby promoting normal antegrade flow in the carotid arteries and other downstream arteries while reducing the likelihood of high blood flow and renal reperfusion injury. The systems and methods of this invention can also improve the incidence of North-South syndrome in patients with impaired lung function, thereby ensuring adequate oxygenated blood flow to the patient's cerebrovascular system.
[0049] refer to Figure 1A This describes an extension cannula 10 suitable for use with a conventional VA-ECMO cannula. The extension cannula 10 includes a shaft 17 extending between a distal region 11 and a proximal region 13 of the extension cannula 10. The shaft 17 is made of a material such as stainless steel rod, which has sufficient rigidity to allow the cannula 10 to be advanced through a conventional ECMO reperfusion cannula, such that the distal region 11 of a self-expanding catheter 12 can be positioned, with its outlet extending beyond the patient's renal artery, and preferably extending in or near the patient's ascending aorta. The self-expanding catheter 12 may optionally include a handle 15 coupled to the shaft 17 at the proximal region 13 of the self-expanding catheter 12 for manipulating the extension cannula 10.
[0050] The self-expanding catheter 12 has an inlet 16 at its proximal end and an outlet 14 at its distal end, and a lumen extending therethrough to allow blood flow. The self-expanding catheter 12 is long enough to extend from the outlet of a conventional VA-ECMO cannula to a location above the patient's renal artery, and more preferably, to the thoracic aorta, for example, 30-120 cm. As described more fully below, the self-expanding catheter 12 includes a self-expanding support structure, such as a mesh, fabric, or braid, covered by a tough and biocompatible covering. Furthermore, as... Figure 1A As shown, the self-expanding catheter 12 may include one or more radiopaque markers 18 disposed along the distal end of the self-expanding catheter 12 near the outlet 14 to allow its location to be determined by fluorescence fluoroscopy. Furthermore, the biocompatible covering near the distal end of the self-expanding catheter 12 may be omitted to allow blood to exit laterally through it and perfuse the thoracic aorta.
[0051] The support structure of the self-expanding catheter 12 can be made of wire mesh, fabric, or braid formed of shape memory metal or stainless steel, allowing the self-expanding catheter 12 to transition from a contracted insertion state to an expanded deployment state. For example... Figure 1BAs depicted, the catheter's support structure can be formed of stainless steel mesh, fabric, or braid, having a predetermined expansion diameter forming a central lumen, such that the catheter can retract when pulled into the smaller diameter delivery sheath 40. Alternatively, the support structure can be formed of a shape memory metal such as a nickel-titanium alloy ("Nitinol") and has a mesh, fabric, or braid having a predetermined expansion diameter forming an internal lumen. In this way, when the catheter is pulled into the delivery sheath 40, the catheter can retract to a retracted insertion state, as described in more detail below.
[0052] The support structure is preferably encapsulated with a biocompatible polymer coating, such as expanded polytetrafluoroethylene (“ePTFE”). In the expanded state, the diameter of the self-expanding catheter 12 is substantially the same as, or even larger than, the internal lumen of a conventional VA-ECMO cannula, thus eliminating the need for a larger opening in the femoral vascular system. For example, in the expanded state, the lumen of the self-expanding catheter 12 can range from 15 Fr to 25 Fr. When inserted through a conventional ECMO cannula, the self-expanding catheter 12 allows enhanced blood flow to the ascending aorta and aortic arch while maintaining the diameter of the femoral artery vascular opening required for introduction of a conventional VA-ECMO return cannula. In some embodiments, the biocompatible polymer coating may include pores that allow lateral perfusion of blood through the material, thereby reducing ejection from the outlet 14.
[0053] Still referencing Figure 1A In a preferred embodiment, the inlet 16 at the proximal end of the self-expanding catheter 12 may have features that facilitate recapture of the self-expanding catheter 12 within the delivery sheath. For example, as shown in FIG1, the self-expanding catheter 12 may have a tapered geometry 19 that facilitates retrieval of the self-expanding catheter 12. For example, the support structure of the self-expanding catheter 12 may include a laterally displaced loop positioned along the edge of the inlet 16 to form the tapered geometry 19. Optionally, the distal end of the shaft 17 may be coupled to a support leg coupled to the proximal end of the support structure of the self-expanding catheter 12, such that advancing the sheath on the support leg causes the support structure of the self-expanding catheter 12 to retract inward to a retracted insertion state, as described in further detail below. Furthermore, the distal end of the self-expanding catheter 12 may include an atraumatic region.
[0054] Now for reference Figure 2This describes an alternative embodiment of the extension cannula 10' of the present invention. In this embodiment, the catheter 12' is made of a soft, flexible material, such as polyethylene or nylon, and may include an orifice that allows some blood to be perfused laterally through the material while directing the majority of the flow through the catheter 12' to the outlet 14'. An elongated shaft 17' serves as a spine to assist in the extension of the catheter 12' through the lumen of a conventional ECMO cannula and to position the inlet 16' near the outlet of the ECMO cannula, and to position the outlet 14' in a distal region 11' above the patient's renal artery, and more preferably, to extend to the patient's thoracic aorta. The shaft 17' may be coupled to the handle 15' of the manipulator 10'. The catheter 12' preferably includes a self-expanding support ring 19' at its proximal end, which expands the opening 16' at the proximal end of the catheter 12' when released from the delivery sheath, as described above regarding Figure 1B The catheter 12' may include a radiopaque marker 18' near the outlet 14'. A support ring 19' ensures that blood flowing through a standard ECMO cannula is injected into the proximal end of the catheter 12' and fully opens the remainder of the catheter 12'. For Figure 1A In one embodiment, at the end of the reperfusion process, the catheter 12' can be contracted by advancing the sheath 40 distally on the elongated shaft 17' and the catheter 12'.
[0055] about Figure 3A This describes a through-hole connector 20 suitable for use with the extension cannula of the present invention. The through-hole connector 20 has a first branch inlet 22 configured to connect to a conventional ECMO machine for receiving oxygenated blood from an ECMO circuit, a second branch inlet 26 having a hemostatic valve welded therein, and an outlet 24 configured to connect to a conventional ECMO cannula. The first branch inlet 22 and the second branch inlet 26 are each in fluid communication with the outlet 24, and each may include an optional hemostatic valve 25, as described below regarding... Figure 3B Therefore, the fluid passage extending between the first branch inlet 22 and outlet 24 allows oxygenated blood received from the ECMO circuit to flow through the conventional ECMO cannula and the self-expanding catheter 12. Furthermore, the fluid passage extending between the second branch inlet 26 and outlet 24 is sized and shaped to allow delivery of the self-expanding catheter 12 in a contracted insertion state (e.g., when positioned within the delivery sheath 40). Thus, the extension cannula 10 or 10' of Figures 1 and 2 can be inserted through the hemostatic valve at the second branch inlet 26 and advanced through the lumen of the conventional ECMO return cannula coupled to outlet 24.
[0056] As will be understood by those skilled in the art, the size and shape of the fluid passage extending between the second branch 26 and the outlet 24 can be configured to allow delivery of other interventional instruments, including, for example, catheters for coronary, peripheral, or cerebrovascular or valvular interventions, and / or pneumatic, rotary, or transvalvular flow pumps. Delivery of the extension cannula 10 or 10' and other large-bore interventional devices or smaller catheters is made possible by the collinearity of the second branch inlet 26 and outlet 24. Unlike Y-shaped connectors used in previously known interventional procedures, the linear alignment of the second branch inlet 26 and outlet 24 of the straight-through connector 20 allows for insertion of devices without bending. Therefore, the linear alignment of the second branch inlet 26 and outlet 24 of the straight-through connector 20 is suitable for delivery of large-bore devices, such as delivery catheters for transcatheter aortic valve replacement (TAVR) valves, Impella pumps, or smaller catheters, such as guiding catheters for coronary, cerebrovascular, or peripheral vascular interventions.
[0057] When delivery of an extension cannula or other interventional device is required, the through-hole connector 20 can be removably coupled to a conventional ECMO return cannula. For example, by clamping the ECMO return cannula to separate it from the ECMO circuit, the through-hole connector 20 can be coupled to the ECMO circuit and the ECMO return cannula via the first branch inlet 22 and outlet 24, respectively, and then the ECMO return cannula can be released. Optionally, the through-hole connector 20 can be integrally constructed as part of the ECMO return cannula, such as a 15, 17, 19, 21, or 25Fr conventional ECMO return cannula. Therefore, when no device is being delivered through the through-hole connector 20, the through-hole connector 20 may include an end cap coupled to the second branch inlet 26. As described above, the second branch inlet 26 may include a hemostatic valve to prevent backflow of blood during delivery of the extension cannula or other interventional device, and the end cap may be coupled to the second branch inlet 26 to prevent further exposure of the hemostatic valve.
[0058] Figure 3A The image also shows an optional side arm 27 that is connected to and in fluid communication with the second branch inlet 26. This side arm 27 can be used to flush the through-hole connector 20, or to fluidly connect the through-hole connector 20 to an antegrade perfusion catheter to perfuse the patient's lower limbs in case of limb ischemia. For example, the antegrade perfusion catheter can be inserted via the side arm 27 through the through-hole connector 20 and a standard ECMO return cannula, and positioned within the patient to deliver oxygenated blood to the patient's lower limbs.
[0059] According to another aspect of the invention, various end caps and fittings can be provided for use with the second branch inlet 26 of the through-hole connector 20. For example, a hemostatic valve 25 may have, for example, a diameter of 3 / 8 inch, sized to selectively close the second branch inlet 26 when not in use. Optionally, the end cap may include a double hemostatic valve, such as... Figure 3B The illustration is designed to prevent backflow of blood through the second branch inlet 26 of the through-hole connector 20 when an extension catheter is inserted through it. As a further alternative, the end cap may have a plug that extends substantially beyond the lumen length of the second branch inlet 26, thereby preventing blood from pooling within the lumen of the second branch inlet 26.
[0060] Now for reference Figure 3B End cap 34 includes a connector portion 35 that can be inserted into an outlet fitting of a conventional ECMO system. End cap 34 preferably includes an internal lumen 36 with a diameter smaller than the lumen of the second branch inlet 26, and is suitable for, for example, drug infusion or pressure / flow monitoring. Furthermore, end cap 34 may include a hemostatic valve located within lumen 36 to prevent backflow of blood passing through it. As will be understood by those skilled in the art, alternatively, or in addition to a hemostatic valve, end cap 34 may include, for example, a spiral (orifice) valve, a ball valve, a double-diaphragm valve, etc. Optionally, lumen 36 may have a diameter selected according to the desired procedure. End cap 34 may be coupled to the second arm of the aforementioned through-hole connector 20 to allow delivery of interventional tools and / or removal of the aforementioned existing ECMO cannula passing through it. End cap 34 may be, for example, a spiral cap that can be rotatably coupled to the through-hole connector and / or an existing ECMO cannula.
[0061] According to another aspect of the invention, the end cap 34 can be directly incorporated into an existing ECMO cannula. For example, without using a through-hole connector to connect the existing ECMO cannula to the ECMO circuit, the end cap 34 can be directly attached to the existing ECMO cannula, for example, as two separate components joined together or as a single component, such that the existing ECMO cannula is in fluid communication with the ECMO circuit via the end cap 34. As described above, the end cap 34 may include one or more hemostatic valves to prevent backflow of blood passing through it. If it is necessary to remove and / or replace the existing ECMO cannula, for example, to replace the existing ECMO cannula with a larger diameter ECMO cannula, the existing ECMO cannula can be removed through the lumen of the end cap 34.
[0062] For example, when ECMO cannula removal is required, a clamp can be applied to the ECMO circuit to detach it from end cap 34. A guidewire can then be introduced through the lumen of end cap 34. The existing ECMO cannula can be removed from the guidewire, and a new, larger ECMO cannula, such as a 19Fr cannula, can be advanced through the lumen of end cap 34 onto the guidewire and positioned within the patient's vascular system. The ECMO circuit can then be reconnected to end cap 34 and released to allow blood to flow again from the ECMO circuit through the new, larger ECMO cannula. Similarly, when interventional instruments (one or more) need to be delivered to the patient, the ECMO circuit can be detached from end cap 34 in the manner described above and reconnected upon completion of the interventional procedure.
[0063] Now for reference Figures 4A to 4C , combined Figure 3A The through-hole connector 20 is schematically depicted. Figure 1A and 1B The operation of the extended cannula implementation method. First, the conventional ECMO cannula 60 is connected to the outlet 24 of the direct-access connector 20 and inserted into the patient's arterial vascular system, for example, via a slit femoral artery, such as... Figure 4A As shown. The outlet line from the ECMO machine is connected to the first branch inlet 22. (As indicated...) Figure 4B As shown, an extension cannula 10, with the self-expanding catheter 12 in a retracted insertion state disposed within the delivery sheath 40, is advanced through the hemostatic valve of the second branch inlet 26 of the straight-through connector 20. The extension cannula 10 is positioned such that the distal end of the self-expanding catheter 12 is positioned at a desired location, for example, within the thoracic aorta, and the proximal end of the self-expanding catheter 12 is located near the distal outlet of a conventional ECMO return catheter, for example, as can be determined under fluoroscopy using, for example, a radiopaque marking strip disposed on the sheath 40.
[0064] The lumen size of the sheath 40 is preferably configured to receive and hold the self-expanding catheter 12 in its retracted insertion state. For example, the lumen diameter of the sheath 40 may be between 1.40 mm and 1.50 mm, and more preferably 1.45 mm. The sheath 40 has an outer diameter sized to allow easy insertion through the lumen of a conventional VA-ECMO reflux cannula. The sheath 40 is slidably disposed on the self-expanding catheter 12 such that it can extend and retract relative to the self-expanding catheter 12, thereby allowing the self-expanding catheter 12 to self-expand from the retracted insertion state to the expanded deployment state.
[0065] Now for reference Figure 4CWhen the sheath 40 and the self-expanding catheter 12 are positioned as described above, the sheath 40 retracts, while the self-expanding catheter 12 is held in place by the elongated shaft 17 and the handle 15, thereby allowing the self-expanding catheter 12 to expand to its deployed state. Since a large portion of the length of the self-expanding catheter 12 extends beyond the distal end of the conventional ECMO return cannula 60, oxygenated blood from the ECMO machine can be delivered to areas inaccessible by the conventional ECMO return cannula. According to one aspect of the invention, other interventional tools, such as vascular catheters, valve catheters, or intra- or trans-aortic valve pumps, for example... The pump (available from Abiomed, Danvers, Massachusetts) can also be inserted through the ECMO cannula via the second branch inlet 26 of the direct connector 20 for additional interventional procedures performed simultaneously with VA-ECMO. Furthermore, arterial repair tools can be delivered to the patient's vascular system via the direct connector to facilitate, for example, the removal of the arterial cannula. For instance, the direct connector can be used to provide re-entry of the sutures into the natural femoral vessels, allowing removal of the ECMO cannula and delivery of vascular closure devices during ECMO extubation, thereby avoiding the need for surgical vascular repair.
[0066] In a preferred embodiment of the extended cannula 10, the length of the self-expanding catheter 12 is between 30 and 40 cm or longer. In this way, blood can be delivered near the patient's thoracic aorta and above the opening of the patient's renal arteries, avoiding high flow velocities near the patient's renal arteries and reducing the risk of perfusion injury. Furthermore, if the distal end of the self-expanding catheter 12 is positioned in the ascending aorta, as can be determined using radiopaque marker 18 under fluoroscopic guidance, the effluent from the self-expanding catheter 12 can provide oxygenated blood to the cardiac arteries near the aortic root and can also provide downstream flow to the carotid arteries and downstream arteries.
[0067] Still referencing Figure 4C When the patient is removed from ECMO, the sheath 40 can be reinserted and advanced on the elongated shaft 17 to retract and retrieve the self-expanding catheter 12. In this configuration, the sheath 40 will first engage the tapered proximal end 19 in the self-expanding catheter 12, such that advancement of the sheath 40 while keeping the shaft 17 stationary will cause the self-expanding catheter 12 to retract inward and return to its reduced diameter, retracted insertion state. The extension cannula 10 and the sheath 40 can then be removed through the hemostatic valve within the second branch inlet 26. Figure 2 The implementation method and operation are basically the same as described above.
[0068] Now for reference Figure 4D Further alternative embodiments of the extension cannula and sheath constructed according to the principles of the present invention are described. The self-expanding catheter 12” is constructed as similar to Figure 4CThe self-expanding conduit 12. For example, the self-expanding conduit 12” has an inlet 16”, an outlet 14”, and one or more radiopaque marking strips 18”, which correspond to the inlet 16, outlet 14, and strip 18” of the self-expanding conduit 12”, respectively. The self-expanding conduit 12” differs from the self-expanding conduit 12 in that, instead of the tapered inlet geometry 19, the self-expanding conduit 12” has a plurality of angled legs 41 that connect the self-expanding conduit 12” to an elongated shaft 17” to facilitate resheathing for removal. Preferably, the angled legs 41 are flexible and of uniform length such that when the distal end of the sheath 40 is advanced over the angled legs 41, the legs bend inward, causing the support structure of the self-expanding conduit 12” to contract inward.
[0069] Furthermore, the sheath 40 can have a quick-change configuration, wherein the length of the sheath 40 is suitable to cover the entire length of the self-expanding conduit 12, 12”, but is connected to the support shaft and a handle coupled to the end of the support shaft. In this way, the sheath 40 can be reverse-loaded on the proximal end of the elongated shaft 17 of the extension sleeve and manipulated via the handle using the support shaft without interfering with the ability to manipulate the proximal end of the shaft 17.
[0070] Still referencing Figure 4D The operation of the optional implementation of the extended sleeve Figures 4A to 4C The implementation method is similar. For example... Figure 4D As shown, the self-expanding conduit 12” and sheath 40 are pushed through the through-hole connector 20 (see Figure 12). Figure 2 The self-expanding catheter 12” is inserted into the lumen of a conventional ECMO return cannula 60, with the sheath 40 in a retracted insertion position. The sheath 40 is withdrawn proximally, while the self-expanding catheter 12” is held in place by an elongated shaft 17”, allowing the self-expanding catheter 12” to self-expand to its predetermined diameter. Once the sheath 40 is fully withdrawn, blood flow through the conventional ECMO return cannula 60 is directed through the angled leg 41 to the outlet of the self-expanding catheter 12”, which bends outward as the support structure of the self-expanding catheter 12” self-expands. After the ECMO procedure is completed, blood flow from the ECMO machine is suspended. The sheath 40 is then postloaded on the elongated shaft 17” of the extension cannula and advanced distally using the support shaft of the sheath 40, as described above. When the distal end of the sheath 40 contacts the angled leg 41, it bends the leg inward and aligns the proximal end of the support structure of the self-expanding catheter 12” to its insertion diameter. Therefore, further distal advancement of the sheath 40 causes the remaining length of the self-expanding catheter 12” to transition to a retracted insertion state, thereby facilitating the removal of the extended cannula.
[0071] Now for reference Figure 5 A flowchart of exemplary steps for improving perfusion during ECMO according to the principles of the present invention is provided. Some steps of method 50 can be found by referring to... Figures 6A to 6E To elaborate further. For example, Figure 6A A standard ECMO cannula 60 is shown, inserted through the patient's femoral artery FA and connected to the ECMO machine 61 via the outlet 24 and first inlet 22 of the direct-connector 20 as described above. Figure 6B As shown, guidewire 62 can be inserted through the second branch inlet 26 and outlet 24 of the through connector 20 and through the ECMO cannula 60 until the distal end of guidewire 62 is advanced to the desired location within the patient's vascular system, such as within the thoracic aorta, such as within the ascending aorta or near the aortic arch.
[0072] In step 51, the distal end of the sheath 40 of the self-expanding catheter 12, positioned therein in a retracted insertion state, is advanced through the ECMO cannula 60, for example, over the guidewire 62, via the straight-through connector 20. The distal end of the sheath 40 is advanced until it is located at the desired central position within the patient's vascular system in step 52, such as... Figure 6C As shown. In step 53, the sheath 40 retracts relative to the self-expanding conduit 12 slidably disposed in the lumen of the sheath 40, while the self-expanding conduit 12 remains stationary, causing the self-expanding conduit 12 to change from a retracted insertion state to an expanded deployment state, as shown. Figure 6D and 6E As shown. Figure 6D A self-expanding catheter 12 that partially and completely expands within the patient's vascular system is shown, and Figure 6E A self-expanding catheter 12 is shown fully expanding in the patient's vascular system, for example, when the self-expanding catheter 12 is fully exposed from the sheath 40. Therefore, in step 54, oxygenated blood can be perfused from the ECMO cannula 60 to a central location in the patient's vascular system, for example, within the ascending aorta or near the aortic arch. Consequently, blood flowing into adjacent vessels—e.g., the coronary arteries and / or carotid arteries—will flow in a more normal antegrade pattern. As will be understood by those skilled in the art, the outlet of the self-expanding catheter 12 may be located within the descending aorta, for example, the portion of the descending aorta below the thoracic cavity near the diaphragm level or the portion of the descending aorta above the diaphragm.
[0073] According to one aspect of the invention, the ECMO pump is programmable to generate pulsatile blood flow to produce pressure fluctuations at the outlet of the self-expanding catheter 12 that mimic the patient's heartbeat. Therefore, in contrast to utilizing continuous flow, the patient may gain significant benefits such as maintaining arterial elasticity and reducing arteriosclerosis. When ECMO treatment is completed, in step 55, the self-expanding catheter 12 can be returned to its contracted insertion state within the lumen of the sheath 40 as described above, and in step 56, the sheath 40 and the self-expanding catheter 12 disposed therein can be removed from the patient.
[0074] Figure 7This is a graph illustrating the stroke risk in patients undergoing various treatments, including VA-ECMO. As shown, patients undergoing VA-ECMO typically have the highest overall stroke risk, such as acute ischemic stroke and hemorrhagic stroke. Based on the principles of the invention, the systems and methods described herein are intended to provide oxygenated blood to the cerebrovascular system and to provide downstream flow from the outlet of a self-expanding catheter. This is expected to reduce the risk of ischemic stroke and decrease blood flow velocity and pressure that could lead to kidney injury.
[0075] about Figure 8 The further anticipated benefits of the system and method of the present invention are described. Figure 8 This illustrates a condition known as "North-South syndrome" that can occur in patients on ECMO, particularly those with impaired lung function. In this condition, although the heart is beating, the blood returning to circulation from the left ventricle may be poorly oxygenated. In this situation, if a conventional ECMO return catheter is used, the oxygenated blood reperfused into the patient mixes with the deoxygenated blood flowing downstream from the lungs, resulting in varying degrees of hypoxia. Because the extended cannula of this invention is designed to deliver blood to the ascending aorta, the system and method of this invention are expected to significantly improve the treatment of impaired lung function and reduce the incidence and severity of North-South syndrome.
[0076] Preclinical data from experiments show that the extended cannula constructed using the principles of this invention exhibits superior performance compared to conventional ECMO reflux cannulas. Figure 9 This is a comparison of standard VA-ECMO cannula insertion and the use of the extension cannula of this invention (during which...). Figure 9 A series of graphs measuring various parameters (defined in the text as "alternative cannula insertion"). Specifically, compared to standard VA-ECMO cannula insertion, the alternative cannula insertion of this invention resulted in a decrease in mean pulmonary arterial pressure (MAP), a decrease in right arterial pressure, a decrease in pulmonary capillary wedge pressure, a decrease in renal artery flow velocity, and a decrease in renal interstitial pressure (organ pressure). These findings suggest that placing an extended cannula can reduce cardiac, pulmonary, and renal injury compared to standard VA-ECMO alone. Specifically, the data show that, compared to standard cannula insertion (delivering blood to the femoral artery), the alternative cannula insertion reduced cardiac pressure (right atrial pressure and pulmonary capillary wedge pressure), normal renal artery flow velocity, and normal renal interstitial (organ) pressure. Further, as... Figure 10As shown, compared to standard VA-ECMO cannula insertion, the alternative cannula insertion of the present invention provides increased pulsating arterial blood flow in the renal and femoral arteries. Compared to sham-operated animals, standard femoral cannula insertion ECMO reduces pulse pressure, e.g., pulsatility, in the renal and femoral arteries. Compared to standard cannula insertion, the alternative cannula insertion (delivering blood to the thoracic aorta) increases pulse pressure, e.g., pulsatility, in the renal and femoral arteries. This improvement in physiological pulsatility is further associated with a reduction in injury.
[0077] Figure 11 and 12 Further comparisons are provided with the alternative cannula insertion method of this invention compared to standard ECMO cannula insertion, demonstrating improved renal artery pulsatility and reduced intrarenal microvascular resistance. Regarding... Figure 11 Compared to standard cannulation, alternative (irrigation) cannulation maintained renal artery pulsatility for 3 hours after infusion. Regarding... Figure 12 Compared to standard cannulation, alternative (irrigation) cannulation maintained pulsatility (renal resistance index) and reduced renal artery microvascular resistance in the renal artery after 2 and 6 hours of pumping. Similarly, Figure 13 The alternative cannula insertion technique of the present invention (“ALT ECMO”) demonstrates that it results in lower levels of kidney injury molecule 1 (KIM-1) in urine, indicating less kidney damage in patients. Compared to standard VA-ECMO, ALT ECMO is associated with lower (normal) levels of the kidney injury marker in urine.
[0078] Figure 14A and 14B Further comparisons of the use of the alternative cannulas of this invention with standard ECMO cannulation are provided, showing significant and unexpected reductions in both left and right ventricular load. Figure 14A It is a graph measuring the relationship between pressure and volume, including the ventricular trace approximately 60 minutes after infarction, after the initiation of arterial ECMO cannulation in the femoral artery at the standard renal outlet, and 10 minutes after standard arterial ECMO cannulation. The area within each pressure-volume loop, called "PVA," is a measurement of the work done by the heart during cardiac circulation. Figure 14AThe figures show that the pressure / volume loop of the left ventricle (LV) was essentially unaffected by ECMO reperfusion. Similarly, the load on the right ventricle (RV) did not experience a significant decrease after standard ECMO cannulation. As a possible explanation, but not intended to be limiting, it is assumed that the load on the left and right ventricles remained essentially unchanged because the continuous high-flow infusion below the renal artery caused stagnation of the blood column in the descending aorta, resulting in a sustained high LV pressure. Therefore, it is thought that the heart must continue to work to overcome the resistance to antegrade blood flow created by the ECMO-infused blood. Thus, during standard ECMO cannulation, the femoral artery delivery of arterial blood pressurizes the entire aorta, thereby increasing the workload that the natural heart must pump.
[0079] On the contrary, such as Figure 14B As shown, when the extension cannula of the present invention is deployed to extend the ECMO outlet in the aortic arch, it is in conjunction with... Figure 14A Compared to standard arterial ECMO cannulation, the load on both the left ventricle (LV) and right ventricle (RV) was significantly reduced after ECMO activation. Specifically, the pressure / volume loop of the LV was significantly reduced, and the pressure / volume loop of the RV was further reduced, demonstrating the effectiveness of the extended cannula of the present invention in reducing cardiac load during ECMO reperfusion. Again, for explanation and not intended to be limiting, it is assumed that the significant reduction in LV and right ventricle load is due to blood delivery to the aortic arch, which increases antegrade blood flow to the descending aorta and arteries adjacent to the aortic arch. Therefore, within 10 minutes of ECMO reperfusion initiation, the resulting positive blood flow fully develops, releasing the LV and resulting in less cardiac output, but with much lower pressure. Furthermore, it is thought that the reduction in load in the LV may facilitate blood flow through the lungs, further reducing RV load. Therefore, by delivering blood within the aortic arch, the arterial tree is not compressed, thus avoiding an increase in pressure load that the heart might otherwise have to bear, making venous drainage of the heart more effective, and thereby reducing RV and LV volumes without increasing ventricular pressure.
[0080] While various illustrative embodiments of the invention have been described above, it will be apparent to those skilled in the art that various changes and modifications can be made thereto without departing from the invention. For example, as will be understood by those skilled in the art, the systems and methods described herein are not limited to use with VA-ECMO systems. For example, the extension cannula of the invention can also be used with, for example, a vein-to-venous ECMO (VV-ECMO) system. Furthermore, the extension cannula and direct-access connector described herein can be used in conjunction with conventional ECMO drainage catheters, allowing the extension cannula to extend from the drainage catheter in the femoral vein to the patient's pulmonary artery or right ventricle, thereby allowing blood to be pumped directly out of the heart, effectively fulfilling the function of a ventricular assist device. The appended claims are intended to cover all such changes and modifications within the true scope of the invention.
Claims
1. An extension cannula system having an inlet and an outlet for use with an ECMO reflux cannula, the extension cannula system comprising: Extension sleeve, comprising: A slender shaft with proximal and distal regions; and A conduit connected to the distal region of the elongated shaft, the conduit having an inlet, an outlet, and an internal lumen, the conduit having a diameter configured to transition between a contracted insertion state and an expanded deployment state; and A through-hole connector having a first branch, a second branch, and an outlet, the first branch being configured to connect to an outlet of an ECMO circuit, the second branch having a lumen configured to allow the extension cannula to be inserted therethrough, and the outlet being configured to connect to the ECMO return cannula. The first and second branches are in fluid communication with the outlet of the through-hole connector, and the second branch is collinear with the outlet of the through-hole connector. The catheter has a selected length such that when the extension cannula is inserted through the lumen of the ECMO return cannula, the inlet of the catheter is in fluid communication with the outlet of the ECMO return cannula, and the outlet of the catheter is located in the patient's thoracic aorta.
2. The extension cannula system of claim 1, wherein the elongated shaft is configured to position the catheter within the ECMO reflux cannula.
3. The extended cannula system according to claim 1, wherein the inner diameter of the catheter is configured to receive at least one of the following: a catheter for coronary artery, peripheral vascular, neurointervention or valvular intervention, a catheter for antegrade limb perfusion, or a catheter for delivery of an intra-aortic pump, a transvalvular pneumatic pump or a cyclone pump.
4. The extension cannula system of claim 1, wherein the catheter includes a support structure encapsulated with a tough biocompatible coating.
5. The extension sleeve system according to claim 4, wherein the support structure comprises a self-expanding mesh, fabric, or braid.
6. The extension sleeve system according to claim 4, wherein the support structure comprises shape memory alloy, plastic or stainless steel.
7. The extension cannula system of claim 4, further comprising a sheath configured to be removably disposed on the catheter to hold the catheter in a retracted insertion state.
8. The extension cannula system of claim 7, wherein the support structure near the inlet of the catheter includes a feature that facilitates the transition of the catheter to the retracted insertion state when the sheath is advanced over the catheter.
9. The extension sleeve system of claim 8, wherein the feature includes a tapered geometry at the proximal end of the support structure.
10. The extension sleeve system of claim 8, wherein the feature includes a plurality of support legs that connect the proximal end of the support structure to the elongated shaft.
11. The extension cannula system of claim 1, wherein the cannula comprises a soft, tough material having one or more pores.
12. The extension sleeve system of claim 1, further comprising an end cap configured to be coupled to the inlet of the second branch of the through-hole connector.
13. The extension cannula system of claim 12, wherein the end cap includes a hemostatic valve.
14. The extension cannula system of claim 13, wherein the end cap includes a double hemostatic valve.
15. The extension cannula system of claim 13, wherein the end cap includes a plug configured to be received within the lumen of the second branch of the through-hole connector to prevent blood pooling within the second branch of the through-hole connector.
16. The extension cannula system of claim 15, wherein the end cap includes a lumen configured to receive at least one of a drug infusion catheter or a pressure or flow sensor.
17. The extension cannula system of claim 12, further comprising a hemostatic valve disposed within the lumen of the end cap, the hemostatic valve being configured to allow unidirectional blood flow from the ECMO circuit to the ECMO return cannula.
18. The extension sleeve system according to claim 1, further comprising: A connection structure that connects the inlet of the conduit to the distal region of the elongated shaft. The elongated shaft is configured to advance the catheter through the lumen of the ECMO reflux cannula to position the inlet of the catheter within the outlet of the ECMO reflux cannula, and The length of the catheter is selected such that when the extension cannula is inserted through the lumen of the ECMO reflux cannula and transitions to the expanded state, the inlet of the catheter is located within the outlet of the ECMO reflux cannula, close to the patient's renal vessels, and the outlet of the catheter extends beyond the outlet of the ECMO reflux cannula and the patient's renal vessels.
19. The extension sleeve system of claim 1, wherein the elongated shaft comprises a stainless steel thiopanthium tube.
20. The extension cannula system of claim 1, wherein the catheter comprises a biocompatible fabric.
21. The extension sleeve system of claim 18, wherein the connection structure comprises one or more rings or supports.
22. The extension sleeve system of claim 18, wherein the connection structure comprises shape memory alloy, plastic, or stainless steel.
23. The extension cannula system of claim 18, further comprising a sheath configured to be removably advanced over the catheter to retract the catheter to the retracted insertion state.
24. The extension cannula system of claim 23, wherein the connection structure facilitates the transition of the catheter to the retracted insertion state as the sheath is advanced over the catheter.
25. The extension sleeve system of claim 24, wherein the connection structure further comprises a tapered geometry.
26. The extension cannula system of claim 24, wherein the connection structure includes a plurality of struts coupled to the proximal end of the catheter.
27. The extension cannula system of claim 11, wherein one or more orifices are provided in the side surface of the conduit to reduce jetting from the outlet.
28. The extended cannula system of claim 1, wherein the length of the catheter is selected such that when the inlet of the catheter is located within the outlet of the ECMO return cannula, positioned within the patient's vascular system proximal to the patient's renal vessels, the catheter transitions to the expanded state in the presence of blood flow from the ECMO return cannula, such that the internal lumen forms a continuous portion of the blood flow path through the lumen, and the outlet of the catheter extends beyond the patient's renal vessels.
29. The extension cannula system of claim 1, wherein the length of the catheter is selected such that when the extension cannula is inserted through the lumen of the ECMO return cannula and transitions to the expanded state, the inlet of the catheter is in fluid communication with the outlet of the ECMO return cannula, the outlet of the catheter extends into the patient's aortic arch, and the internal lumen forms a continuous portion of the blood flow path through the lumen to deliver blood from the ECMO return cannula to the patient's aortic arch, thereby reducing the cardiac load on the patient's left and right ventricles.
Citation Information
Patent Citations
Guide extension catheter with grooved push member segment
US10485956B2
Hemostasis valve
US5125903A
Hemostatic valve
US5195980A
Hemostatic gasket and valve assembly
US5269764A
Perfusion catheter providing segmented flow regions and methods of use
US6083198A
